Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Douglas A Jabs, MD MBA
CCTand Evidence Synthesis, JHU, Bloomberg School of Public Health
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre for Eye Research Australia
East Melbourne, Victoria, Australia
- University of Sydney
Sydney, Australia
- University Hospital Birmingham
Edgbaston, Birmingham, United Kingdom
- Bradford Teaching Hospital Nhs Foundation Trust
Bradford, United Kingdom
- Cambridge University Nhs Trust
Cambridge, United Kingdom
- University Hospitals of Leicester
Leicester, United Kingdom
- Moorfields Eye Hospital Nhs Foundation Trust
London, United Kingdom
- Jules Stein Eye Institute, Ucla
Los Angeles, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine
Miami, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- National Eye Institute
Bethesda, Maryland, United States
- Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
- University of Michigan Health System, Kellogg Eye Center
Ann Arbor, Michigan, United States
- Washington University
St Louis, Missouri, United States
- Midatlantic Retina, Wills Eye Hospital
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Tennessee Retina
Nashville, Tennessee, United States
- Vanderbilt University Eye Institute
Nashville, Tennessee, United States
- Retinal Consultants of Texas
Bellaire, Texas, United States
- University of Utah, Moran Eye Center
Salt Lake City, Utah, United States
- University of Washington, Medicine Eye Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Sept 2019
- Primary completion
- 2 Apr 2024
- Completion
- 9 Sept 2024
- Last update posted
- 16 May 2025
- Registered enrollment
- 227
- Registry id
- NCT03828019
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.